Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
John Abele, Founder, Boston Scientific Corporation, explains the challenges behind the exponential growth in the advancement of technology. He gives 6 guidelines to address the ethical dilemmas of modern…
Larry Smarr, Founding Director, CALIT2, examines the 90% of cells in the body that aren’t human, most of which reside in the large intestine. A recent study used…
How do small companies create groundbreaking changes through the internet? Brad Templeton of Foresight Nanotech Institute and former chairman of Electronic Frontier Foundation explains how “stupid networks” allow…
Why try to develop new drugs and therapies when we can repurpose old ones? Atul J. Butte, MD, PhD, Chief of Division of Systems Medicine at Stanford School…
Neil Jacobstein, Co-Chair of A.I. and Robotics, Singularity University, discusses the implications of introducing physician’s assistant AI mobile devices as a clinical decision support package for physicians. The…
John Abele, Co-Founder and Director or Boston Scientific, talks about how while people know when they aren’t feeling well, it’s often difficult to understand why. Doctors can use…
John Abele, Founder, Boston Scientific Corporation, discusses the dilemma of regulating medicine when it comes to the risk of not doing something versus the risk of doing something.…
Chris Longhurst, MD, Associate Professor, Stanford Medical School, gives insight on the future of a fully digital healthcare system. By 2020, a nationwide learning healthcare system will allow…
Steven Edelman, MD and Robert Henry, MD explain the clinical characteristics that would lead to the use of a DPP-4 inhibitor versus a GLP-1 receptor agonist. They discuss…
Brad Templeton, Board Member, Foresight Nanotech Institute, explains the next great medical revolution, the self-driving car. Car accidents are the 7th leading cause of death in the US,…
